Joël Eyer

3.1k total citations
85 papers, 2.4k citations indexed

About

Joël Eyer is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joël Eyer has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 35 papers in Cell Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joël Eyer's work include Skin and Cellular Biology Research (26 papers), RNA Interference and Gene Delivery (20 papers) and Nanoparticle-Based Drug Delivery (13 papers). Joël Eyer is often cited by papers focused on Skin and Cellular Biology Research (26 papers), RNA Interference and Gene Delivery (20 papers) and Nanoparticle-Based Drug Delivery (13 papers). Joël Eyer collaborates with scholars based in France, Canada and United States. Joël Eyer's co-authors include Alan Peterson, Rodolphe Perrot, Raphaël Bergès, J.F. Leterrier, Alan C. Peterson, Arnaud Bocquet, Patrick Saulnier, Julien Balzeau, Dario Carradori and Véronique Préat and has published in prestigious journals such as Nature, Neuron and Journal of Neuroscience.

In The Last Decade

Joël Eyer

81 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joël Eyer France 25 1.1k 846 619 457 298 85 2.4k
Marimélia Porcionatto Brazil 29 933 0.9× 637 0.8× 502 0.8× 123 0.3× 185 0.6× 92 2.4k
Kazuhiko Watabe Japan 30 946 0.9× 343 0.4× 1.0k 1.6× 577 1.3× 140 0.5× 116 2.8k
Christian Bernreuther Germany 34 1.4k 1.3× 237 0.3× 654 1.1× 249 0.5× 221 0.7× 75 3.3k
Allan J. Bieber United States 30 1.5k 1.4× 578 0.7× 1.2k 1.9× 380 0.8× 141 0.5× 60 3.5k
Ursula Schenk Italy 24 1.7k 1.6× 626 0.7× 902 1.5× 146 0.3× 264 0.9× 32 3.6k
Martin J. Carden United Kingdom 26 1.8k 1.7× 1.5k 1.8× 763 1.2× 468 1.0× 147 0.5× 40 3.2k
Gabriele Loers Germany 31 1.4k 1.3× 364 0.4× 980 1.6× 128 0.3× 111 0.4× 92 2.7k
Eun‐Mi Hur South Korea 23 1.2k 1.1× 477 0.6× 768 1.2× 190 0.4× 58 0.2× 45 2.3k
Jane Loughlin United Kingdom 20 822 0.8× 173 0.2× 511 0.8× 232 0.5× 196 0.7× 31 2.4k
Mala V. Rao United States 26 1.0k 1.0× 1.1k 1.3× 817 1.3× 721 1.6× 55 0.2× 37 2.7k

Countries citing papers authored by Joël Eyer

Since Specialization
Citations

This map shows the geographic impact of Joël Eyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël Eyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël Eyer more than expected).

Fields of papers citing papers by Joël Eyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël Eyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël Eyer. The network helps show where Joël Eyer may publish in the future.

Co-authorship network of co-authors of Joël Eyer

This figure shows the co-authorship network connecting the top 25 collaborators of Joël Eyer. A scholar is included among the top collaborators of Joël Eyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël Eyer. Joël Eyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eyer, Joël, Tony Breton, Véronique Montembault, et al.. (2025). One-Step Synthesis of Poly(2-alkyl-2-oxazoline)-Coated Gold Nanospheres: A Greener Approach for Biomedical Uses. Biomacromolecules. 26(3). 1923–1934.
3.
4.
D’Amone, Stefania, Memona Khan, Joël Eyer, et al.. (2025). Doxorubicin and NFL-TBS.40-63 peptide loaded gold nanoparticles as a multimodal therapy of glioblastoma. Discover Nano. 20(1). 72–72.
5.
Saulnier, Patrick, et al.. (2023). Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel. Biomaterials Advances. 153. 213549–213549. 10 indexed citations
6.
Griveau, Audrey, et al.. (2022). Characterization and quantification of the interaction between the NFL-TBS.40‐63 peptide and lipid nanocapsules. International Journal of Pharmaceutics X. 4. 100127–100127. 7 indexed citations
7.
Saulnier, Patrick, et al.. (2021). Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?. SHILAP Revista de lepidopterología. 3. 791596–791596. 18 indexed citations
8.
Izmiryan, Araksya, Zhenlin Li, Fatiha Nothias, et al.. (2021). Inactivation of vimentin in satellite glial cells affects dorsal root ganglion intermediate filament expression and neuronal axon growth in vitro. Molecular and Cellular Neuroscience. 115. 103659–103659. 7 indexed citations
9.
Eyer, Joël, et al.. (2019). The NFL-TBS.40–63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells. International Journal of Pharmaceutics. 566. 218–228. 12 indexed citations
10.
Carradori, Dario, Patrick Saulnier, Véronique Préat, Anne des Rieux, & Joël Eyer. (2016). NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo. Journal of Controlled Release. 238. 253–262. 54 indexed citations
11.
Eyer, Joël, et al.. (2013). Review on intermediate filaments of the nervous system and their pathological alterations. Histochemistry and Cell Biology. 140(1). 13–22. 68 indexed citations
12.
Balzeau, Julien, et al.. (2013). The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells. Biomaterials. 34(13). 3381–3389. 53 indexed citations
13.
Bergès, Raphaël, Julien Balzeau, Alan C. Peterson, & Joël Eyer. (2012). A Tubulin Binding Peptide Targets Glioma Cells Disrupting Their Microtubules, Blocking Migration, and Inducing Apoptosis. Molecular Therapy. 20(7). 1367–1377. 49 indexed citations
15.
Fressinaud, Catherine & Joël Eyer. (2012). Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro. Neurochemistry International. 62(3). 306–313. 6 indexed citations
16.
Leterrier, J.F., Paul A. Janmey, & Joël Eyer. (2009). Microtubule-independent regulation of neurofilament interactions in vitro by neurofilament-bound ATPase activities. Biochemical and Biophysical Research Communications. 384(1). 37–42. 4 indexed citations
17.
Letournel, Franck, et al.. (2003). Stable Tubule Only Polypeptides (STOP) Proteins Co-Aggregate with Spheroid Neurofilaments in Amyotrophic Lateral Sclerosis. Journal of Neuropathology & Experimental Neurology. 62(12). 1211–1219. 16 indexed citations
18.
Soares, Sylvia, Ysander von Boxberg, Marie‐Christine Lombard, et al.. (2002). Phosphorylated MAP1B is induced in central sprouting of primary afferents in response to peripheral injury but not in response to rhizotomy. European Journal of Neuroscience. 16(4). 593–606. 28 indexed citations
19.
Stone, J. D., Alan Peterson, Joël Eyer, Thomas G. Oblak, & Dale W. Sickles. (1999). Axonal Neurofilaments Are Nonessential Elements of Toxicant-Induced Reductions in Fast Axonal Transport: Video-Enhanced Differential Interference Microscopy in Peripheral Nervous System Axons. Toxicology and Applied Pharmacology. 161(1). 50–58. 20 indexed citations
20.
Leterrier, J.F., et al.. (1994). Naftidrofuryl, a Putative Activator of Neuron Survival, Stimulates the Expression of Neurofilament Heavy Subunit in Cultivated Spinal Cord Neurons from Chicken. Biochemical and Biophysical Research Communications. 200(1). 504–512. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026